Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiation in Patients With Surgically Resectable Esophageal Cancer: a Pilot Randomized Study
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
compliance with assigned neoadjuvant treatment
- >50% patients allocated for randomization will start and complete treatment without major protocol violation
5 weeks for chemoradiation arm, 6 weeks for chemotherapy arm
Yes
Canada: Health Canada
CDHA 147937-7
NCT01404156
December 2011
February 2013
Name | Location |
---|